Back

Methylome-Wide Association Study of Obsessive-Compulsive Disorder

Hoeffler, K. D.; Stavrum, A.-K.; Halvorsen, M. W.; Eide, T. O.; Hagen, K.; Hoeberg, A.; Nordic OCD and Related Disorders Consortium (NORDiC), ; Kvale, G.; Crowley, J. J.; Haavik, J.; Ressler, K. J.; Hansen, B.; Klengel, T.; Le Hellard, S.

2025-07-21 psychiatry and clinical psychology
10.1101/2025.07.18.25331794 medRxiv
Show abstract

BackgroundObsessive-compulsive disorder (OCD) is a debilitating psychiatric condition influenced by both genetic and environmental risk factors. Epigenetic modifications, such as DNA methylation, may offer insights into biologically meaningful differences associated with the disorder. MethodsWe conducted the largest methylome-wide association study (MWAS) of OCD to date, analyzing saliva DNA samples from 414 individuals with OCD and 384 controls using the Illumina EPICv2 array. Differentially methylated positions (DMPs) and regions (DMRs) were identified, with additional analyses including sex-stratified comparisons, methylation quantitative trait loci (mQTL) mapping, and assessments of cell-type composition differences. ResultsWe identified 35 DMPs and 17 DMRs associated with OCD, mapping to genes involved in neurotransmission, neurodevelopment, synaptic function, and gene regulation. Sex-stratified analyses revealed additional sex-specific methylation signals, highlighting biological differences between males and females. Most associated loci were influenced by genetic variation (mQTLs). Differences in estimated cell composition and the identification of immune-related genes suggest a potential role for immune system processes. Correlation analyses between brain and saliva methylation indicated that several findings may reflect brain-relevant biology. ConclusionsOur findings emphasize the importance of integrating epigenetic, genetic, and sex-specific data to advance our understanding of OCD. DNA methylation may ultimately contribute to progress toward clinically relevant precision medicine approaches.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
22 papers in training set
Top 0.1%
23.0%
2
Translational Psychiatry
219 papers in training set
Top 0.1%
23.0%
3
Molecular Psychiatry
242 papers in training set
Top 0.6%
4.4%
50% of probability mass above
4
Biological Psychiatry
119 papers in training set
Top 0.9%
3.7%
5
American Journal of Psychiatry
20 papers in training set
Top 0.1%
3.1%
6
Psychological Medicine
74 papers in training set
Top 0.7%
2.9%
7
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.6%
2.8%
8
Frontiers in Psychiatry
83 papers in training set
Top 1%
2.7%
9
Neuropsychopharmacology
134 papers in training set
Top 1%
2.1%
10
Biological Psychiatry Global Open Science
54 papers in training set
Top 0.4%
2.1%
11
European Neuropsychopharmacology
15 papers in training set
Top 0.2%
2.1%
12
Journal of Psychiatric Research
28 papers in training set
Top 0.3%
2.1%
13
Journal of Affective Disorders
81 papers in training set
Top 0.8%
2.1%
14
Acta Neuropsychiatrica
12 papers in training set
Top 0.3%
1.9%
15
Brain, Behavior, & Immunity - Health
27 papers in training set
Top 0.2%
1.7%
16
JAMA Psychiatry
13 papers in training set
Top 0.3%
1.5%
17
Psychiatry Research
35 papers in training set
Top 1%
1.4%
18
PLOS ONE
4510 papers in training set
Top 63%
0.9%
19
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
0.9%
20
Schizophrenia Bulletin
29 papers in training set
Top 0.6%
0.8%
21
NeuroImage: Clinical
132 papers in training set
Top 3%
0.8%
22
European Psychiatry
10 papers in training set
Top 0.6%
0.8%
23
The British Journal of Psychiatry
21 papers in training set
Top 0.9%
0.8%
24
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 1%
0.7%
25
Addiction Biology
47 papers in training set
Top 0.8%
0.7%
26
Psychiatry and Clinical Neurosciences
11 papers in training set
Top 0.5%
0.7%
27
Psychiatry Research: Neuroimaging
16 papers in training set
Top 0.4%
0.5%